companydata.dkEmbryoTrans Biotech ApS: Financial statements 2017
CVR: 36701676
EmbryoTrans Biotech ApS (CVR 36701676) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 1,838,431 and a net result of DKK 172,405 compared with DKK 132,445 the year before. That is an increase of 4% compared with the year before. Equity amounted to DKK 377,402. The solvency ratio was 29.7%.
- Gross Profit
- 1,838,431 kr.
- Profit/Loss
- 172,405 kr.
- Equity
- 377,402 kr.
- Total Assets
- 1,270,171 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 1.8 mio. | 172 t. | 377 t. | - |
| 2016 | - | 1.8 mio. | 132 t. | 455 t. | - |
Find more companies like EmbryoTrans Biotech ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
EmbryoTrans Biotech ApS has published its annual report for 2016. Gross profit came to DKK 1,767,468, and the net result was DKK 132,445.
About EmbryoTrans Biotech ApS
EmbryoTrans Biotech ApS was a Danish company of the type Anpartsselskab based in Hundested, founded in 2015 and dissolved in 2022. The company was registered under the industry Detailhandel med medicinske og ortopædiske artikler. The company has 4 employees. In 2020, the company reported a gross profit of DKK 520,019 and a net result of DKK -10,407 compared with DKK 23,111 the year before. Equity amounted to DKK 242,326.